| Teva Pharma AG - Neotigason 25 mg, Kapseln | | 49227 | | 02 | | Neotigason 25 mg | | Kapseln | | D05BB02 | | Acitretin | | 19.03.1990 | | |
| | Composition | | acitretinum 25 mg, glucosum liquidum dispersione desiccatum 41 mg, gelatina, cellulosum microcristallinum, natrii ascorbas corresp. natrium 0.8 mg, Kapselhülle: gelatina, E 171, E 172, Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 172, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Acitretine | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Acitretine | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Ammonii Hydroxidum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Glucosum Liquidum Dispersione Desiccatum | 41 mg | | | Lacca | | Drucktinte | | Sodium Ascorbate | | | | Pro Capsula | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 035 | 30 Gélule(s) | 60.50 | 81.50 | A | LS | Non | | 043 | 100 Gélule(s) | 183.30 | 214.05 | A | LS | Non |
|
|
